Sylvie Lambert
Scientific Series: November 11, 2024
The TEMPO Canadian Cancer Trial: advancing self-management for men with prostate cancer and their caregivers
TEMPO, which stands for a web-based, Tailored, sElf-Management PrOgram, was developed to support men with prostate cancer and their caregivers. Initially piloted through a randomized controlled trial, TEMPO demonstrated promising improvements in coping skills, communication, and physical activity levels among participants. This presentation outlined TEMPO’s initial development and pilot study findings. Speakers introduced the latest, large-scale sequential multiple assignment randomized trial (SMART) examining TEMPO’s efficacy and cost-effectiveness compared to usual care. This multi-stage, SMART seeks to evaluate the delivery of TEMPO using a stepped-care approach on anxiety and quality of life outcomes for patients and caregivers. Attendees gained insights into the methodology and anticipated impacts of this unique program, designed for self-directed use without healthcare professional involvement.
At the end of this presentation, participants were able to:
Understand TEMPO’s development and pilot findings: explore the foundations of TEMPO, including feedback from preliminary studies and the pilot trial, which informed the program’s self-management tools for patients and caregivers.
Describe the objectives and design of the national trial: gain insights into the structure of the latest SMART design for men with prostate cancer and their caregivers.
Appreciate the role of lay guidance in self-management programs: understand the rationale and anticipated benefits of introducing lay guidance for non-responding participants and its hypothesized impact on anxiety and overall program effectiveness.
Prof. Sylvie Lambert is an Associate Professor and Associate Director of Research at McGill University's Ingram School of Nursing. She also holds a Canada Research Chair (Tier 2) in Illness Self-Management Support Interventions for Patients and Their Family Caregivers. Her research focuses on developing and evaluating sustainable self-management interventions for patients with cancer and other chronic illnesses, as well as their caregivers. Prof. Lambert has been recognized for her contributions to research. In 2024, she received the Canadian Association of Psychosocial Oncology (CAPO) Research Excellence Award. Throughout her career, Prof. Lambert has secured more than $7M in funding. Notably, she was awarded a $300,000 health equity research grant from the Canadian Cancer Society for a project aimed at improving communication between cancer patients from culturally and linguistically diverse backgrounds and clinicians. Her presentation today will be focusing on her recent CIHR project grant for $761,000. Prof. Lambert has an extensive publication record, with over 127 peer-reviewed articles and more than 100 conference presentations. Her work has significantly advanced the fields of patient education, caregiver research, and self-management interventions, contributing to improved outcomes for patients and their families.